Neuland Laboratories Ltd
NEULANDLAB price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- NEULANDLAB
- MB Code
- MBEQU902
- ISIN
- INE794A01010
- BSE code
- 524558
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 776.25 Cr
- Net profit
- 212.67 Cr
- EPS
- 165.76
- YoY revenue
- +136.40%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for NEULANDLAB
Neuland Laboratories said Q4 FY26 total income jumped 134.9% YoY, driven by commercial CMS projects, with stronger margins and earnings d…
Neuland Laboratories' Q4 FY26 earnings call reported record revenue of INR 788.7 crore, up 134.9% YoY, driven by commercial CMS projects …
Neuland Laboratories rose nearly 8% on May 13 after Q4 profit jumped 665% to ₹212.7 crore, revenue doubled to ₹776.25 crore and EBITDA su…
EPS 165.76 vs est. 79.72
Beat estimates by 107.92%
Neuland Laboratories' Q4 net profit jumped over 7x to ₹213 crore on strong US and Europe export orders; FY26 revenue rose 37%. Board also…
EPS 31.62 vs est. 57.65
Missed estimates by 45.15%
Neuland Laboratories reported a net profit of ₹129 crore for Q2 FY26, a 166% increase from last year. Revenue rose 63.7% to ₹516 crore, w…
EPS 75.49 vs est. 56.02
Beat estimates by 34.76%
Price returns
Historical performance
Technicals
Indicator consensus